2nd International Workshop On Long Acting Anti-Infectives (LAAI) 2026

About this Program

The 2nd International Workshop on Long-Acting Anti-Infectives (LAAI) is a dynamic forum advancing the development, implementation, and scale-up of long-acting and extended-release (LA/ER) anti-infective therapies.

This year’s program examined the evolving landscape of HIV prevention and treatment, while broadening discussions to tuberculosis, malaria, hepatitis, and non-TB mycobacterial diseases. Sessions explored innovative delivery platforms, behavioral and adherence strategies, drug resistance, and implementation challenges across diverse populations.

Through interactive talks, panel discussions, and debates, participants engaged with the latest scientific and programmatic insights shaping the next generation of long-acting therapies. By fostering collaboration among academia, industry, and global health partners, LAAI aimed to drive innovation that improves access, adherence, and long-term outcomes across infectious diseases.